Halozyme Therapeutics, Inc. vs. Vaxcyte, Inc. Common Stock
Halozyme Therapeutics, Inc. and Vaxcyte, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | PCVX | |
|---|---|---|
| Market Cap | $12.29 billion | $10.98 billion |
HALO leads on 1 of 1 size & scale factors.
Valuation
| HALO | PCVX | |
|---|---|---|
| Price / Book | — | 3.98 |
HALO and PCVX split the valuation factors evenly.
Risk & Sentiment
| HALO | PCVX | |
|---|---|---|
| Short Interest | 9.79% | 0.13% |
PCVX leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, PCVX overview, PCVX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.